SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-20-004560
Filing Date
2020-04-29
Accepted
2020-04-29 08:54:39
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A kala-20200429xdefa14a.htm DEFA14A 28018
2 GRAPHIC kala-20200429xdefa14ag001.gif GRAPHIC 52483
3 GRAPHIC kala-20200429xdefa14ag002.gif GRAPHIC 100833
4 GRAPHIC kala-20200429xdefa14ag003.jpg GRAPHIC 72793
5 GRAPHIC kala-20200429xdefa14ag004.gif GRAPHIC 4247
  Complete submission text file 0001558370-20-004560.txt   346623
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38150 | Film No.: 20827612
SIC: 2834 Pharmaceutical Preparations